Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.
2.

Master of surgery in Archiv für Klinische Chirurgie.

Beger HG, Gansauge F.

Langenbecks Arch Surg. 2010 Apr;395 Suppl 1:17-21. doi: 10.1007/s00423-010-0620-7. Epub 2010 Mar 11.

PMID:
20221626
3.

The use of antibiotics for acute pancreatitis: is there a role?

Beger HG, Gansauge F, Poch B, Schwarz M.

Curr Infect Dis Rep. 2009 Mar;11(2):101-7.

PMID:
19239799
4.

The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis.

Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG.

Intensive Care Med. 2000 Mar;26 Suppl 2:S159-64. doi: 10.1007/BF02900730.

PMID:
18470712
5.

Duodenum-preserving total pancreatic head resection for cystic neoplastic lesions in the head of the pancreas.

Beger HG, Gansauge F, Siech M, Schwarz M, Poch B.

J Hepatobiliary Pancreat Surg. 2008;15(2):149-56. doi: 10.1007/s00534-007-1227-4. Epub 2008 Apr 6.

PMID:
18392707
6.

Duodenum-preserving total pancreatic head resection for cystic neoplasm: a limited but cancer-preventive procedure.

Beger HG, Rau BM, Gansauge F, Schwarz M, Siech M, Poch B.

Langenbecks Arch Surg. 2008 Jul;393(4):589-98. doi: 10.1007/s00423-008-0323-5. Epub 2008 Apr 1.

PMID:
18379818
7.

Pancreatic cancer--low survival rates.

Beger HG, Rau B, Gansauge F, Leder G, Schwarz M, Poch B.

Dtsch Arztebl Int. 2008 Apr;105(14):255-62. doi: 10.3238/arztebl.2008.0255. Epub 2008 Apr 4.

8.

Duodenum-preserving subtotal and total pancreatic head resections for inflammatory and cystic neoplastic lesions of the pancreas.

Beger HG, Rau BM, Gansauge F, Poch B.

J Gastrointest Surg. 2008 Jun;12(6):1127-32. doi: 10.1007/s11605-008-0472-4. Epub 2008 Feb 26. Review.

PMID:
18299945
9.

The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer.

Gansauge F, Ramadani M, Schwarz M, Beger HG, Lotspeich E, Poch B.

Hepatogastroenterology. 2007 Apr-May;54(75):917-20.

PMID:
17591092
10.

Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats.

Schwarz M, Poch B, Isenmann R, Kriese D, Rozdzinski E, Beger HG, Gansauge F.

Langenbecks Arch Surg. 2007 May;392(3):365-70. Epub 2007 Mar 23.

PMID:
17380347
11.

Systemic immune dysfunction in pancreatic cancer patients.

Poch B, Lotspeich E, Ramadani M, Gansauge S, Beger HG, Gansauge F.

Langenbecks Arch Surg. 2007 May;392(3):353-8. Epub 2007 Jan 19.

PMID:
17235586
12.

Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis.

Nair J, Gansauge F, Beger H, Dolara P, Winde G, Bartsch H.

Antioxid Redox Signal. 2006 May-Jun;8(5-6):1003-10. Erratum in: Antioxid Redox Signal. 2006 Sep-Oct;8(9-10):1905.

PMID:
16771690
13.

Antibiotic prophylaxis in severe acute pancreatitis.

Beger HG, Rau B, Isenmann R, Schwarz M, Gansauge F, Poch B.

Pancreatology. 2005;5(1):10-9. Epub 2005 Mar 15. Review.

14.

Influence of PMN leukocyte-mediated pancreatic damage on the systemic immune response in severe acute pancreatitis in rats.

Wittel UA, Rau B, Gansauge F, Gansauge S, Nussler AK, Beger HG, Poch B.

Dig Dis Sci. 2004 Aug;49(7-8):1348-57.

PMID:
15387367
15.

Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.

Beger C, Ramadani M, Meyer S, Leder G, Krüger M, Welte K, Gansauge F, Beger HG.

Clin Cancer Res. 2004 Jun 1;10(11):3780-7.

16.

Comparative analysis of extracellular matrix proteins in chronic pancreatitis: differences between pancreatic head and tail.

Muehling B, Kolb A, Ramadani M, Schmidt E, Gansauge F, Beger HG.

Pancreas. 2004 Mar;28(2):174-80.

PMID:
15028950
17.

[Nitrogen monoxide and oxygen radicals work contrarily on proliferation behavior of human fibroblasts].

Gansauge S, Gansauge F, Nüssler AK, Schoenberg MH, Beger HG.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):323-7. German.

PMID:
14518269
18.

[Prognostic value of molecular biologogy and immunologic parameters in human pancreatic carcinoma].

Gansauge F, Gansauge S, Müller J, Schmid E, Beger HG.

Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):69-72. German.

PMID:
14518215
19.

Treatment of pancreatic cancer: challenge of the facts.

Beger HG, Rau B, Gansauge F, Poch B, Link KH.

World J Surg. 2003 Oct;27(10):1075-84. Epub 2003 Aug 21.

PMID:
12925907
20.

[Pancreatic cancer. The relative importance of neoadjuvant therapy].

Beger HG, Poch B, Schwarz M, Gansauge F.

Chirurg. 2003 Mar;74(3):202-7. Review. German.

PMID:
12647076
21.

Cyclooxygenase-2 is overexpressed in chronic pancreatitis.

Schlosser W, Schlosser S, Ramadani M, Gansauge F, Gansauge S, Beger HG.

Pancreas. 2002 Jul;25(1):26-30.

PMID:
12131767
22.

Overexpression of caspase-1 in pancreatic disorders: implications for a function besides apoptosis.

Ramadani M, Gansauge F, Schlosser S, Yang Y, Beger HG, Gansauge S.

J Gastrointest Surg. 2001 Jul-Aug;5(4):352-8.

PMID:
11985974
23.

NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial.

Gansauge F, Ramadani M, Pressmar J, Gansauge S, Muehling B, Stecker K, Cammerer G, Leder G, Beger HG.

Langenbecks Arch Surg. 2002 Mar;386(8):570-4. Epub 2002 Feb 13.

PMID:
11914932
24.

Pancreatic cancer: who benefits from curative resection?

Beger HG, Gansauge F, Leder G.

Can J Gastroenterol. 2002 Feb;16(2):117-20. Review.

PMID:
11875596
25.

Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival.

Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger HG.

Cancer. 2001 Dec 1;92(11):2746-53.

PMID:
11753947
26.

Low serum levels of CD44, CD44v6, and neopterin indicate immune dysfunction in chronic pancreatitis.

Schlosser W, Gansauge F, Schlosser S, Gansauge S, Beger HG.

Pancreas. 2001 Nov;23(4):335-40.

PMID:
11668200
27.

Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.

Poch B, Gansauge F, Schwarz A, Seufferlein T, Schnelldorfer T, Ramadani M, Beger HG, Gansauge S.

Pancreas. 2001 Oct;23(3):280-7.

PMID:
11590324
28.

Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines.

Weber CK, Sommer G, Michl P, Fensterer H, Weimer M, Gansauge F, Leder G, Adler G, Gress TM.

Gastroenterology. 2001 Sep;121(3):657-67.

PMID:
11522750
29.

Anti-ICAM-1 antibody modulates late onset of acinar cell apoptosis and early necrosis in taurocholate-induced experimental acute pancreatitis.

Rau B, Paszkowski A, Esber S, Gansauge F, Poch B, Beger HG, Möller P.

Pancreas. 2001 Jul;23(1):80-8.

PMID:
11451152
30.
31.
32.
33.

Distributional and functional alterations of immunocompetent peripheral blood lymphocytes in patients with chronic pancreatitis.

Gansauge F, Gansauge S, Eh M, Schlosser W, Ramadani M, Kern P, Beger HG.

Ann Surg. 2001 Mar;233(3):365-70.

34.

Modulation of endogenous nitric oxide synthase in experimental acute pancreatitis: role of anti-ICAM-1 and oxygen free radical scavengers.

Rau B, Bauer A, Wang A, Gansauge F, Weidenbach H, Nevalainen T, Poch B, Beger HG, Nussler AK.

Ann Surg. 2001 Feb;233(2):195-203.

35.

Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis.

Wallrapp C, Hähnel S, Boeck W, Soder A, Mincheva A, Lichter P, Leder G, Gansauge F, Sorio C, Scarpa A, Gress TM.

Int J Cancer. 2001 Feb 1;91(3):340-4.

36.

Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant.

Rau B, Steinbach G, Baumgart K, Gansauge F, Grünert A, Beger HG.

Crit Care Med. 2000 Mar;28(3):736-42.

PMID:
10752823
37.

Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells.

Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK.

Cancer. 2000 Oct 1;89(7):1440-7.

PMID:
11013356
38.
40.

Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?

Rau B, Poch B, Gansauge F, Bauer A, Nüssler AK, Nevalainen T, Schoenberg MH, Beger HG.

Ann Surg. 2000 Mar;231(3):352-60.

41.

The role of immunocytes in acute and chronic pancreatitis: when friends turn into enemies.

Beger HG, Gansauge F, Mayer JM.

Gastroenterology. 2000 Mar;118(3):626-9. Review. No abstract available.

PMID:
10702216
42.

The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation.

Poch B, Gansauge F, Rau B, Wittel U, Gansauge S, Nüssler AK, Schoenberg M, Beger HG.

FEBS Lett. 1999 Nov 19;461(3):268-72.

43.

Inhibition of epidermal growth factor-induced interleukin-1beta-converting enzyme expression reduces proliferation in the pancreatic carcinoma cell line AsPC-1.

Schlosser S, Gansauge F, Schnelldorfer T, Ramadani M, Schwarz A, Beger HG, Gansauge S.

Cancer Res. 1999 Sep 15;59(18):4551-4.

44.
45.

Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells.

Grewe M, Gansauge F, Schmid RM, Adler G, Seufferlein T.

Cancer Res. 1999 Aug 1;59(15):3581-7.

46.

[Effect of therapy on survival of patients with pancreatic carcinoma].

Warszawski N, Link KH, Warszawski A, Lutz MP, Gansauge F, Schneider BM, Röttinger EM.

Strahlenther Onkol. 1999 Jul;175(7):315-9. German.

PMID:
10432992
47.

p53 in relation to therapeutic outcome of locoregional chemotherapy in pancreatic cancer.

Gansauge F, Gansauge S, Link KH, Beger HG.

Ann N Y Acad Sci. 1999 Jun 30;880:281-7.

PMID:
10415873
48.

Basal expression and cytokine induction of intercellular adhesion molecule-1 in human pancreatic cancer cell lines.

Shimoyama S, Gansauge F, Gansauge S, Kaminishi M, Beger HG.

J Exp Clin Cancer Res. 1999 Mar;18(1):107-10.

PMID:
10374689
49.
50.

Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients.

Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T.

Arch Surg. 1999 May;134(5):526-32.

PMID:
10323425

Supplemental Content

Loading ...
Support Center